Roche, GSK melanoma pill combinations look similar in showdown

Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses.

Sep 29, 2014 12:00 PM EDT